Statin-Induced Lung Injury;Colchicine-Induced Rhabdomyolysis Caused by Interaction with Clarithromycin;Disulfiram Ethanol Reaction Mimicking Anaphylactic,Cardiogenic,and Septic Shock;Weight Gain with Abdominal Enlargement in a Patient Receiving Tocilizumab;Nilotinib-Associated Acute Pancreatitis
Restricted accessResearch articleFirst published online April, 2013
Statin-Induced Lung Injury;Colchicine-Induced Rhabdomyolysis Caused by Interaction with Clarithromycin;Disulfiram Ethanol Reaction Mimicking Anaphylactic,Cardiogenic,and Septic Shock;Weight Gain with Abdominal Enlargement in a Patient Receiving Tocilizumab;Nilotinib-Associated Acute Pancreatitis
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers.
Get full access to this article
View all access options for this article.
References
1.
HillCZeitzCKirkmanB.Dermatomyositis with lung involvement in a patient treated with simvastatin. Aust N S Z L Med.1995;25:745–746.
2.
FernandezABKarasRHAlsheikh-AliAA. Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports. Chest.2008;134:824–830.
